Ibex Investment Holdings II LLC

DENVER, CO · Founded 2016 · CIK 0001787360 · Biotech

Therapeutic antibodies, gene therapies, and regenerative medicine programs

ibex.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.0M
1 Form D · Sep 2019
85 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1854InCarda Therapeutics, Inc.—$66M
1855Recombinetics, Inc.—$45M
1856Dracen Pharmaceuticals, Inc.—$19M
1857Ibex Investment Holdings II LLC—$1.0M
1858Purinomia Biotech, Inc.—$10M
1859Apollomics Inc.—$10M
1860Syenex, Inc.—$8.9M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Brian AbramsExecutive Officer
  • Justin BorusExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.